Additional file 5: of Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

Table S5. Relationship between plasma exosomal miR-196a level and clinicopathologic features in HNC; Table S6. Cox proportional hazards regression models for estimating overall survival related to Table S5. (DOC 86 kb)